Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis

  title={Probiotic Mix VSL\#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis},
  author={Houssam E. Mardini and Alla Y. Grigorian},
  journal={Inflammatory Bowel Diseases},
Background:VSL#3 is a probiotic mix preparation reported to be effective in the treatment of mild to moderately active ulcerative colitis. We aimed to perform a systematic review of the literature and a meta-analysis of studies on its efficacy. Methods:The searched databases included PubMed, Scopus, and ScienceDirect. The Mantel–Haenszel method was used to pool the effect- ize across studies, and the odds ratios (ORs) and 95% confidence intervals (CIs) of experiencing a specific outcome were… 
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis
FMT is potentially useful in UC disease management but better-designed RCTs are still required to confirm the findings before wide adoption is suggested and basic guidelines are needed imminently to identify the right patient population and to standardize the process of FMT.
Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial
The probiotic formula when taken orally over the 12-week period did not significantly alter the microbiota measured in this population of people with celiac disease, and no statistically significant changes between the groups in the faecal microbiota counts or blood safety measures were revealed.
The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis
It is concluded that a validated scale is necessary to determine the state of patients with UC and probiotics containing bifidobacteria are promising for the treatment of active UC.
Probiotic Bacterial and Fungal Strains: Claims with Evidence
The evidence on bacterial and yeast probiotics has considerably expanded during recent years, and accumulated data allow one to make informed decisions about the effectiveness of probiotics and about how to reduce the use of those without proven efficacy.
Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis
The overall methodological quality of the current MAs/SRs in the field of probiotics for IBD and pouchitis was found to be low to moderate, and most of the MAs andSRs suggested that probiotics had potential benefits for patients with ulcerative colitis but failed to show effectiveness in the induction and maintenance of remission in Crohn’s disease.
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Modulation of intestinal flora represents a very interesting therapeutic target, although it still deserves some doubts and limitations, and future studies should be encouraged to provide new understanding about its therapeutical role.
Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
It is found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies, including digestive systemic diseases (gastrointestinal diseases and hepatic diseases), obesity and diabetes, allergic diseases, nervous systemic diseases, atherosclerosis, bone diseases, and female reproductive systemic diseases.


VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
Treatment of patients with mild to moderate UC, not responding to conventional therapy, with VSL#3 resulted in a combined induction of remission/response rate of 77% with no adverse events.
Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis
This is the first pediatric, randomized, placebo-controlled, double-blind trial that suggests the efficacy and safety of a highly concentrated mixture of probiotic bacterial strains (VSL#3) in active UC and demonstrates its role in maintenance of remission.
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
VSL#3 supplementation is safe and able to reduce UCDAI scores in patients affected by relapsing mild-to-moderate UC who are under treatment with 5-ASA and/or immunosuppressants at stable doses.
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn's Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials
Administration of probiotics results in additional benefit in inducing remission of patients with UC and can provide the similar effect as 5-aminosalicylic acid on maintaining remission of UC, although no additional adverse events presented.
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
Balsalazide/VSL#3 may be a very good choice in the treatment of active mild-to-moderate active ulcerative colitis instead of balsalAZide alone or mesalazine.
Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2011
The clinical studies regarding probiotics before October 2007 are outlined, providing new insights into the role of probiotics for inducing and maintaining remission of IBD, and some of the breakthroughs are highlighted, especially regarding induction of remission for ulcerative colitis.
Probiotics in the treatment of inflammatory bowel disease.
Not all probiotic bacteria have similar therapeutic effects, soorously designed, controlled clinical trials, to investigate the unresolved issues related to efficacy, dose, duration of use, single or multistrain formulation, and the concomitant use of prebiotics, synbiotics or antibiotics, are vital.
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis
It is shown that treatment of UC patients with probiotic VSL#3 and corticosteroids induced “favorable” intestinal DC function in vivo, increasing regulatory cytokines and lowering proinflammatory cytokine and TLR expression.
How to Review a Meta-analysis.
  • M. Russo
  • Psychology
    Gastroenterology & hepatology
  • 2007
The techniques used in meta-analysis provide a structured and standardized approach for analyzing prior findings in a specific topic in the literature that provides a quantitative estimate for the effect of a treatment intervention or exposure.